Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide
A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.
1. A method of inhibiting active-oxygen production in a subject, comprising:
administering a composition having D-allose as an active ingredient to said subject,
wherein said subject has at least one morbid state or disease selected from the group consisting of (i) skin-flap necrosis, (ii) renal disorders selected from the group consisting of acute renal failure and uremia and (iii) ophthalmologic diseases selected from the group consisting of retina denaturation, retinopathy of prematurity, cataract, and ophthalmia, wherein said D-allose is administered in amount of 0.01 to 2,000 mg per kg of subject weight.
2. The method of claim 1 , wherein said composition is a functional food or a drug.
3. A method of inhibiting proliferation of cancer cells in a patient, comprising:
administering a composition having D-allose as an active ingredient to said patient,
wherein said cancer cells are hepatic cancer cells, uterine cancer cells, ovarian cancer cells, skin cells, or lymphoma cells, wherein said D-allose is administered in amount of 0.01 to 2,000 mg per kg of subject weight.
4. The method of claim 3 , wherein said composition is a functional food or a drug.
5. A method of inhibiting necrosis of neurons caused by a brain disorder in a patient, comprising:
administering a composition having D-allose as an active ingredient to said patient,
wherein said brain disorder is selected from the group consisting of a temporary brain ischemia fit, cerebral stroke, and traumatic epilepsy, wherein said D-allose is administered in amount of 0.01 to 2,000 mg per kg of subject weight.
6. The method of claim 5 , wherein said composition is a functional food or a drug.
7. The method of claim 3 , wherein said cancer cells are hepatic cancer cells.
8. The method of claim 3 , wherein said cancer cells are skin cancer cells.